(19)
(11) EP 4 816 417 A1

(12)

(43) Date of publication:
07.10.2026 Bulletin 2026/41

(21) Application number: 24827351.8

(22) Date of filing: 22.11.2024
(51) International Patent Classification (IPC): 
C08B 37/00(2006.01)
C08B 37/02(2006.01)
(52) Cooperative Patent Classification (CPC):
C08B 37/0009; C08B 37/0018; C08B 37/0021
(86) International application number:
PCT/US2024/056998
(87) International publication number:
WO 2025/117349 (05.06.2025 Gazette 2025/23)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 28.11.2023 US 202363603232 P

(71) Applicants:
  • Danisco USA Inc.
    New Century, KS 66031 (US)
  • Nutrition & Biosciences USA 4, Inc.
    Wilmington, Delaware 19803 (US)

(72) Inventors:
  • FOERTSCH, Sebastian
    29699 WALSRODE (DE)
  • ENGELHARDT, Juergen
    29699 WALSRODE (DE)
  • ADDEN, Roland
    29699 WALSRODE (DE)
  • LU, Helen S. M.
    WILMINGTON, Delaware 19803 (US)

(74) Representative: Mewburn Ellis LLP 
Aurora Building Counterslip
Bristol BS1 6BX
Bristol BS1 6BX (GB)

   


(54) ESTERIFICATION OF ALPHA-GLUCAN COMPRISING ALPHA-1,6 GLYCOSIDIC LINKAGES